CryoLife (United States)
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for CryoLife (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
43%
Total
Publications
206
Total Open
Publications
88
Total
Citations
4K
Open Access
Percentage
43%
Total
Publications
206
Total Open
Publications
88
Total
Citations
4K
Breakdown
Publisher Open
21%
Both
16%
Other Platform Open
5%
Closed
58%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 28%
21
Hybrid 20%
15
No Guarantees 52%
40
Other Platform Open
Domain 64%
28
Institution 41%
18
Preprint 11%
5
Other Internet 7%
3
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 28 |
doaj.org OAI-PMH Repository | Institution | 9 |
Royal Netherlands Academy of Arts and Sciences | Institution | 2 |
LA Referencia | Institution | 2 |
DOI | Other Internet | 2 |
bioRxiv | Preprint | 2 |
Unknown Repository | Other Internet | 1 |
University of Oxford | Institution | 1 |
University of Milano-Bicocca | Institution | 1 |
University of Arizona | Institution | 1 |